vs
Side-by-side financial comparison of NextPlat Corp (NXPL) and Precipio, Inc. (PRPO). Click either name above to swap in a different company.
NextPlat Corp is the larger business by last-quarter revenue ($12.8M vs $6.8M, roughly 1.9× Precipio, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -40.2%, a 47.9% gap on every dollar of revenue. On growth, Precipio, Inc. posted the faster year-over-year revenue change (28.4% vs -21.1%). Precipio, Inc. produced more free cash flow last quarter ($291.0K vs $-339.0K). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs -14.4%).
Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.
NXPL vs PRPO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.8M | $6.8M |
| Net Profit | $-5.1M | $526.0K |
| Gross Margin | 14.3% | 45.9% |
| Operating Margin | -28.9% | 7.9% |
| Net Margin | -40.2% | 7.7% |
| Revenue YoY | -21.1% | 28.4% |
| Net Profit YoY | -70.6% | 244.1% |
| EPS (diluted) | — | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $12.8M | $6.8M | ||
| Q3 25 | $13.8M | $6.9M | ||
| Q2 25 | $13.2M | $5.6M | ||
| Q1 25 | $14.5M | $4.9M | ||
| Q4 24 | $16.2M | $5.3M | ||
| Q3 24 | $15.4M | $5.3M | ||
| Q2 24 | $17.0M | $4.5M | ||
| Q1 24 | $17.5M | $3.5M |
| Q4 25 | $-5.1M | $526.0K | ||
| Q3 25 | $-2.2M | $-79.0K | ||
| Q2 25 | $-1.8M | $74.0K | ||
| Q1 25 | $-1.3M | $-884.0K | ||
| Q4 24 | $-3.0M | $-365.0K | ||
| Q3 24 | $-4.2M | $-626.0K | ||
| Q2 24 | $-5.3M | $-1.2M | ||
| Q1 24 | $-1.5M | $-2.1M |
| Q4 25 | 14.3% | 45.9% | ||
| Q3 25 | 19.9% | 43.6% | ||
| Q2 25 | 21.8% | 43.2% | ||
| Q1 25 | 23.8% | 43.6% | ||
| Q4 24 | 16.8% | 49.8% | ||
| Q3 24 | 23.2% | 43.1% | ||
| Q2 24 | 34.5% | 38.1% | ||
| Q1 24 | 27.8% | 26.5% |
| Q4 25 | -28.9% | 7.9% | ||
| Q3 25 | -14.5% | -0.9% | ||
| Q2 25 | -13.8% | -14.6% | ||
| Q1 25 | -10.2% | -17.5% | ||
| Q4 24 | -14.1% | -6.3% | ||
| Q3 24 | -52.1% | -11.3% | ||
| Q2 24 | -64.1% | -26.8% | ||
| Q1 24 | -10.5% | -59.6% |
| Q4 25 | -40.2% | 7.7% | ||
| Q3 25 | -15.9% | -1.1% | ||
| Q2 25 | -13.5% | 1.3% | ||
| Q1 25 | -9.2% | -18.0% | ||
| Q4 24 | -18.6% | -6.9% | ||
| Q3 24 | -27.4% | -11.9% | ||
| Q2 24 | -31.3% | -27.1% | ||
| Q1 24 | -8.5% | -59.8% |
| Q4 25 | — | $0.36 | ||
| Q3 25 | — | $-0.05 | ||
| Q2 25 | — | $0.05 | ||
| Q1 25 | $-0.05 | $-0.59 | ||
| Q4 24 | — | $-0.22 | ||
| Q3 24 | $-0.22 | $-0.42 | ||
| Q2 24 | — | $-0.83 | ||
| Q1 24 | $-0.08 | $-1.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $13.7M | $2.7M |
| Total DebtLower is stronger | $1.3M | $83.0K |
| Stockholders' EquityBook value | $17.3M | $14.6M |
| Total Assets | $27.5M | $21.3M |
| Debt / EquityLower = less leverage | 0.07× | 0.01× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $13.7M | $2.7M | ||
| Q3 25 | $13.9M | $2.3M | ||
| Q2 25 | $16.6M | $1.1M | ||
| Q1 25 | $17.7M | $1.0M | ||
| Q4 24 | $20.0M | $1.4M | ||
| Q3 24 | $20.4M | $1.1M | ||
| Q2 24 | $24.9M | $1.3M | ||
| Q1 24 | $23.5M | $776.0K |
| Q4 25 | $1.3M | $83.0K | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $1.2M | — | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | $1.4M | $383.0K | ||
| Q3 24 | $1.5M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $1.4M | — |
| Q4 25 | $17.3M | $14.6M | ||
| Q3 25 | $21.4M | $13.7M | ||
| Q2 25 | $23.5M | $12.3M | ||
| Q1 25 | $25.3M | $11.7M | ||
| Q4 24 | $27.3M | $12.1M | ||
| Q3 24 | $22.5M | $11.9M | ||
| Q2 24 | $26.5M | $12.1M | ||
| Q1 24 | $31.2M | $12.8M |
| Q4 25 | $27.5M | $21.3M | ||
| Q3 25 | $30.0M | $21.2M | ||
| Q2 25 | $31.0M | $18.8M | ||
| Q1 25 | $35.2M | $17.8M | ||
| Q4 24 | $37.1M | $17.0M | ||
| Q3 24 | $41.1M | $17.0M | ||
| Q2 24 | $51.5M | $17.3M | ||
| Q1 24 | $65.1M | $16.6M |
| Q4 25 | 0.07× | 0.01× | ||
| Q3 25 | 0.05× | — | ||
| Q2 25 | 0.05× | — | ||
| Q1 25 | 0.05× | — | ||
| Q4 24 | 0.05× | 0.03× | ||
| Q3 24 | 0.07× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | 0.04× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-302.0K | $366.0K |
| Free Cash FlowOCF − Capex | $-339.0K | $291.0K |
| FCF MarginFCF / Revenue | -2.6% | 4.3% |
| Capex IntensityCapex / Revenue | 0.3% | 1.1% |
| Cash ConversionOCF / Net Profit | — | 0.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $359.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-302.0K | $366.0K | ||
| Q3 25 | $-2.7M | $10.0K | ||
| Q2 25 | $-1.0M | $353.0K | ||
| Q1 25 | $-2.1M | $-44.0K | ||
| Q4 24 | $-476.0K | $565.0K | ||
| Q3 24 | $-4.6M | $41.0K | ||
| Q2 24 | $2.3M | $500.0K | ||
| Q1 24 | $-2.7M | $-667.0K |
| Q4 25 | $-339.0K | $291.0K | ||
| Q3 25 | — | $-44.0K | ||
| Q2 25 | $-1.1M | $294.0K | ||
| Q1 25 | $-2.1M | $-182.0K | ||
| Q4 24 | $-508.0K | — | ||
| Q3 24 | $-4.7M | $-68.0K | ||
| Q2 24 | $2.2M | — | ||
| Q1 24 | $-2.7M | — |
| Q4 25 | -2.6% | 4.3% | ||
| Q3 25 | — | -0.6% | ||
| Q2 25 | -8.0% | 5.2% | ||
| Q1 25 | -14.3% | -3.7% | ||
| Q4 24 | -3.1% | — | ||
| Q3 24 | -30.6% | -1.3% | ||
| Q2 24 | 13.2% | — | ||
| Q1 24 | -15.7% | — |
| Q4 25 | 0.3% | 1.1% | ||
| Q3 25 | 0.0% | 0.8% | ||
| Q2 25 | 0.1% | 1.0% | ||
| Q1 25 | 0.2% | 2.8% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.6% | 2.1% | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.4% | — |
| Q4 25 | — | 0.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.77× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NXPL
| Healthcare Operations | $9.0M | 70% |
| Ecommerce Revenue | $3.8M | 30% |
PRPO
Segment breakdown not available.
